Velázquez Rodríguez Enrique, Favela Pérez Eddie
Médicos Postgraduados en Electrofisiología Cardiaca, UNAM, Servicio de Electrofisiologia del Hospital de Cardiologia, Centro Médico Nacional Siglo XXI, IMSS.
Arch Cardiol Mex. 2006 Apr-Jun;76(2):169-78.
The endpoint of successful treatment of slow pathway ablation is elimination of AV nodal reentrant tachycardia (AVNRT). However, the mechanism of elimination is not well understood and is controversial if complete elimination or persistent dual AV nodal physiology is associated with a higher success, recurrence and/or complications rate.
The purpose was to examine the results after slow pathway ablation in AVNRT and changes in AV nodal conduction in patients with and without loss of dual AV nodal physiology.
The study included 106 patients (age 47 +/- 17 years). In 64% with elimination of inducible AVNRT still had dual AV nodal physiology (group I) and absent in 36%, group II). Both, anterograde fast pathway and slow pathway effective refractory period (ERP) showed a tendency to decrease but without statistical significance: 340 +/- 39 ms to 329 +/- 45 ms, 290 +/- 16 to 279 +/- 43 ms respectively, p = NS. In group II, anterograde fast pathway ERP decreased significantly 328 +/- 83 ms to 282 +/- 75 ms, p < 0.001. Anterograde Wenckebach cycle length increased in both groups: 360 +/- 65 to 375 +/- 61 ms, p < 0.05 group I, and 351 +/- 20 to 381 +/- 14 ms, p < 0.001 group II.
Ablation procedures of the AV node slow pathways that eliminate AVNRT modify the AV node electrophysiologic conduction properties. These modifications are more important in patients with complete elimination of dual AV nodal physiology; nonetheless, in a high rate of patients the elimination is incomplete but without reinduction of clinical tachycardia. It has been suggested that elimination of the AVNRT despite the persistence of dual AV nodal physiology is due to the presence of more than one AV node slow pathway with different electrophysiological properties.
慢径消融成功治疗的终点是消除房室结折返性心动过速(AVNRT)。然而,消除机制尚未完全明确,且对于完全消除或持续存在双房室结生理功能是否与更高的成功率、复发率和/或并发症发生率相关存在争议。
旨在研究AVNRT患者慢径消融后的结果以及双房室结生理功能未丧失和丧失的患者房室结传导的变化。
该研究纳入了106例患者(年龄47±17岁)。64%消除可诱发AVNRT的患者仍具有双房室结生理功能(I组),36%的患者无此功能(II组)。顺向快径和慢径有效不应期(ERP)均有缩短趋势,但无统计学意义:分别从340±39毫秒降至329±45毫秒,从290±16毫秒降至279±43毫秒,p=无显著性差异。在II组中,顺向快径ERP显著降低,从328±83毫秒降至282±75毫秒,p<0.001。两组的顺向文氏周期长度均增加:I组从360±65毫秒增至375±61毫秒,p<0.05;II组从351±20毫秒增至381±14毫秒,p<0.001。
消除AVNRT的房室结慢径消融手术改变了房室结的电生理传导特性。这些改变在完全消除双房室结生理功能的患者中更为重要;尽管如此,在相当一部分患者中,消除并不完全,但临床心动过速未再诱发。有人提出,尽管双房室结生理功能持续存在,但AVNRT得以消除是由于存在多条具有不同电生理特性的房室结慢径。